AU2016902883A0 - Insulin Analogs - Google Patents

Insulin Analogs

Info

Publication number
AU2016902883A0
AU2016902883A0 AU2016902883A AU2016902883A AU2016902883A0 AU 2016902883 A0 AU2016902883 A0 AU 2016902883A0 AU 2016902883 A AU2016902883 A AU 2016902883A AU 2016902883 A AU2016902883 A AU 2016902883A AU 2016902883 A0 AU2016902883 A0 AU 2016902883A0
Authority
AU
Australia
Prior art keywords
insulin analogs
insulin
analogs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2016902883A
Inventor
Michael C. Lawrence
John Gerbrandt Tasman Menting
Brian Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
La Trobe University
Walter and Eliza Hall Institute of Medical Research
Original Assignee
La Trobe University
Walter and Eliza Hall Institute of Medical Research
Filing date
Publication date
Application filed by La Trobe University, Walter and Eliza Hall Institute of Medical Research filed Critical La Trobe University
Publication of AU2016902883A0 publication Critical patent/AU2016902883A0/en
Priority to IL264330A priority Critical patent/IL264330B1/en
Priority to CA3030930A priority patent/CA3030930A1/en
Priority to MA045727A priority patent/MA45727A/en
Priority to MX2019000829A priority patent/MX2019000829A/en
Priority to AU2017298565A priority patent/AU2017298565B2/en
Priority to BR112019000991A priority patent/BR112019000991A2/en
Priority to PCT/AU2017/050758 priority patent/WO2018014091A1/en
Priority to KR1020197004760A priority patent/KR102529353B1/en
Priority to US16/319,450 priority patent/US11248034B2/en
Priority to RU2019100497A priority patent/RU2769476C2/en
Priority to CN202310855095.4A priority patent/CN116874584A/en
Priority to JP2019503259A priority patent/JP7143275B2/en
Priority to EP17830123.0A priority patent/EP3487876A4/en
Priority to SG11201900181RA priority patent/SG11201900181RA/en
Priority to KR1020237015079A priority patent/KR20230070049A/en
Priority to NZ750355A priority patent/NZ750355B2/en
Priority to CN201780050247.6A priority patent/CN110072884B/en
Priority to CR20190096A priority patent/CR20190096A/en
Assigned to LA TROBE UNIVERSITY, THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH reassignment LA TROBE UNIVERSITY Amend patent request/document other than specification (104) Assignors: THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH
Priority to PH12019500090A priority patent/PH12019500090A1/en
Priority to CL2019000159A priority patent/CL2019000159A1/en
Priority to ZA2019/01095A priority patent/ZA201901095B/en
Priority to AU2021269301A priority patent/AU2021269301B2/en
Priority to US17/568,698 priority patent/US20220340636A1/en
Priority to JP2022146483A priority patent/JP2022191233A/en
Abandoned legal-status Critical Current

Links

AU2016902883A 2016-04-07 2016-07-22 Insulin Analogs Abandoned AU2016902883A0 (en)

Priority Applications (24)

Application Number Priority Date Filing Date Title
CR20190096A CR20190096A (en) 2016-07-22 2017-07-21 INSULIN ANALOGUES
EP17830123.0A EP3487876A4 (en) 2016-07-22 2017-07-21 Insulin analogs
SG11201900181RA SG11201900181RA (en) 2016-07-22 2017-07-21 Insulin analogs
CA3030930A CA3030930A1 (en) 2016-07-22 2017-07-21 Insulin analogs
KR1020237015079A KR20230070049A (en) 2016-07-22 2017-07-21 Insulin analogs
AU2017298565A AU2017298565B2 (en) 2016-07-22 2017-07-21 Insulin analogs
BR112019000991A BR112019000991A2 (en) 2016-07-22 2017-07-21 insulin analogue, pharmaceutical composition, method for treating and / or preventing an insulin related condition, method for decreasing blood glucose levels, use of insulin analogue, replanning method or modification of a polypeptide which is known to bind to an insulin receptor, polypeptide, isolated molecule, method for identifying a compound that binds to the insulin receptor, computer based method for identifying a compound that mimics insulin activity, compound identified using a method, polypeptide crystal, structure of the polypeptide, use of structure, use of structural model, peptide, method for increasing insulin receptor activation in a subject, method for lowering blood sugar in a subject, method for treating type 1 diabetes in a subject, and therapeutic protein
PCT/AU2017/050758 WO2018014091A1 (en) 2016-07-22 2017-07-21 Insulin analogs
KR1020197004760A KR102529353B1 (en) 2016-07-22 2017-07-21 insulin analogues
US16/319,450 US11248034B2 (en) 2016-07-22 2017-07-21 Insulin analogs
RU2019100497A RU2769476C2 (en) 2016-07-22 2017-07-21 Insulin analogues
CN202310855095.4A CN116874584A (en) 2016-07-22 2017-07-21 Insulin analogues
JP2019503259A JP7143275B2 (en) 2016-07-22 2017-07-21 insulin analog
IL264330A IL264330B1 (en) 2016-07-22 2017-07-21 An insulin analog, pharmaceutical composition comprising it and its uses
MA045727A MA45727A (en) 2016-07-22 2017-07-21 INSULIN ANALOGUES
MX2019000829A MX2019000829A (en) 2016-07-22 2017-07-21 Insulin analogs.
NZ750355A NZ750355B2 (en) 2017-07-21 Insulin analogs
CN201780050247.6A CN110072884B (en) 2016-07-22 2017-07-21 Insulin analogues
PH12019500090A PH12019500090A1 (en) 2016-04-07 2019-01-14 Insulin analogs
CL2019000159A CL2019000159A1 (en) 2016-07-22 2019-01-21 Insulin analogues
ZA2019/01095A ZA201901095B (en) 2016-07-22 2019-02-20 Insulin analogs
AU2021269301A AU2021269301B2 (en) 2016-07-22 2021-11-16 Insulin Analogs
US17/568,698 US20220340636A1 (en) 2016-07-22 2022-01-04 Insulin analogs
JP2022146483A JP2022191233A (en) 2016-07-22 2022-09-14 Insulin analogs

Publications (1)

Publication Number Publication Date
AU2016902883A0 true AU2016902883A0 (en) 2016-08-04

Family

ID=

Similar Documents

Publication Publication Date Title
EP3286169A4 (en) Novel compounds
EP3325449A4 (en) Compounds
EP3229877A4 (en) Incremental syringe
EP3265150A4 (en) Auto-injector
EP3291676A4 (en) Mitragynine analogs and uses thereof
EP3194411A4 (en) Nucleotide analogs
EP3185927A4 (en) Syringe accessory
EP3244950A4 (en) Respiratory interface
EP3341404A4 (en) Novel insulin analogs and use thereof
EP3261443A4 (en) Desacetoxytubulysin h and analogs thereof
EP3251707A4 (en) Infusion set
EP3437680A4 (en) High-slidability syringe
EP3127570A4 (en) Syringe
EP3332819A4 (en) Syringe
EP3407974A4 (en) Amlexanox analogs
EP3281641A4 (en) Medicine
EP3255044A4 (en) Diaza-benzofluoranthrene compounds
EP3348292A4 (en) Infusion set
EP3243541A4 (en) Syringe
EP3409310A4 (en) Syringe
EP3355888B8 (en) Hemi-synthetic trilobine analogs for use as a drug
EP3372264A4 (en) Syringe
EP3406230A4 (en) Cannula
EP3204347A4 (en) Compounds
ZA201901095B (en) Insulin analogs